ArticleDermatology and therapy2025
High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).
Kave Shams et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.